Adams Street Partners’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
DG
Adams Street Partners's HCAT Position: Q4 2022 in Review
Adams Street Partners sold out of Health Catalyst (HCAT) in Q4 2022, closing a stake of 34,157 shares — an estimated $331K sold.
Adams Street Partners first reported a position in HCAT in Q3 2020 and held it in 6 quarters. The position peaked at $8.77M in Q4 2020. 167 funds tracked by Wall St. Rank hold HCAT as of Q4 2022.
- Adams Street Partners reported no remaining Health Catalyst position as of Q4 2022 after selling out during the quarter.
- Adams Street Partners sold 34,157 Health Catalyst shares in Q4 2022, an estimated $331K.
- Adams Street Partners first reported a position in Health Catalyst in Q3 2020 and held it in 6 quarters.
- Adams Street Partners's Health Catalyst position peaked at $8.77M in Q4 2020.
- 167 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2022.
Based on Adams Street Partners's 13F filing for Q4 2022, filed 15 Feb 2023.